Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Strategies for the use of Ginkgo biloba extract, EGb 761 ® , in the treatment and management of mild cognitive impairment in Asia: Expert consensus
Nagaendran Kandiah, Yee Fai Chan, Christopher Chen, et al.
CNS Neuroscience & Therapeutics (2020) Vol. 27, Iss. 2, pp. 149-162
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Diagnosis and Treatment for Mild Cognitive Impairment: A Systematic Review of Clinical Practice Guidelines and Consensus Statements
Yaxin Chen, Ning Liang, Xiaoling Li, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 106
Perioperative neurocognitive disorders: A narrative review focusing on diagnosis, prevention, and treatment
Hao Kong, Long‐Ming Xu, Dong‐Xin Wang
CNS Neuroscience & Therapeutics (2022) Vol. 28, Iss. 8, pp. 1147-1167
Open Access | Times Cited: 95
Ginkgo biloba: A Leaf of Hope in the Fight against Alzheimer’s Dementia: Clinical Trial Systematic Review
Guilherme Lopes de Oliveira Pagotto, Livia Maria Oliveira dos Santos, Najwa Osman, et al.
Antioxidants (2024) Vol. 13, Iss. 6, pp. 651-651
Open Access | Times Cited: 13
Clinical practice guidelines for assessment and management of mild neurocognitive disorder
Alka A. Subramanyam, Shipra Singh, Nitin Raut
Indian Journal of Psychiatry (2025) Vol. 67, Iss. 1, pp. 21-40
Open Access | Times Cited: 1
Ginkgo biloba Extract EGb 761 in the Treatment of Patients with Mild Neurocognitive Impairment: A Systematic Review
Jakub Hort, Thomas Duning, Robert Hoerr
Neuropsychiatric Disease and Treatment (2023) Vol. Volume 19, pp. 647-660
Open Access | Times Cited: 19
A randomized, open-label clinical trial in mild cognitive impairment with EGb 761 examining blood markers of inflammation and oxidative stress
Xavier Morató, Marta Marquié, Juan Pablo Tartari, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 19
Heart–brain interaction in cardiogenic dementia: pathophysiology and therapeutic potential
Jiaxu Liu, Guangxu Xiao, Yujuan Liang, et al.
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access | Times Cited: 7
Emerging antioxidant therapies in Friedreich’s ataxia
Fred Jonathan Edzeamey, Zenouska Ramchunder, Charareh Pourzand, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 7
Efficacy and safety of Ginkgo biloba extract as an adjuvant in the treatment of Chinese patients with sudden hearing loss: a meta-analysis
Chao Yuan, Huan Zhang, Cuicui Sun, et al.
Pharmaceutical Biology (2023) Vol. 61, Iss. 1, pp. 610-620
Open Access | Times Cited: 11
Effects of non-pharmacological interventions on the depressive outcomes in people with mild cognitive impairment: an overview of systematic reviews
Chen Yaxin, Yan Li-jiao, Zhao Chen, et al.
Frontiers in Psychiatry (2025) Vol. 15
Open Access
Promising Natural Remedies for Alzheimer’s Disease Therapy
Amin Mahmood Thawabteh, Aseel Wasel Ghanem, Sara AbuMadi, et al.
Molecules (2025) Vol. 30, Iss. 4, pp. 922-922
Open Access
Current status and future directions for the diagnosis and management of mild cognitive impairment in Southeast Asia: A SEACURE consensus paper
Gaurav Bhalla, Pricilia Tanoto, Ashwati Vipin, et al.
The Journal of Prevention of Alzheimer s Disease (2025), pp. 100110-100110
Open Access
Effect of ashwagandha ( Withania somnifera ) extract with Sominone (Somin-On™) to improve memory in adults with mild cognitive impairment: A randomized, double-blind, placebo-controlled study
Hari Prakash, Deo Nidhi Mishra
Journal of Psychopharmacology (2025)
Closed Access
Current Progress on Neuroprotection Induced by Artemisia, Ginseng, Astragalus, and Ginkgo Traditional Chinese Medicines for the Therapy of Alzheimer’s Disease
Qin Li, Limor Rubin, Marta Silva, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-21
Open Access | Times Cited: 16
Ginkgo biloba extract (EGb-761) confers neuroprotection against ischemic stroke by augmenting autophagic/lysosomal signaling pathway
Rui Zang, F Ling, Zhiyuan Wu, et al.
Journal of Neuroimmunology (2023) Vol. 382, pp. 578101-578101
Closed Access | Times Cited: 7
A mixture of extracts from natural ingredients reduces the neurotoxic polarization of microglia via modulating NF‐κB/NF‐E2‐related factor 2 activation
Shuge Gui, Junjun Ni, Shinsuke Mizutani, et al.
Food Science & Nutrition (2024) Vol. 12, Iss. 5, pp. 3745-3758
Open Access | Times Cited: 2
Naoxin’an capsules protect brain function and structure in patients with vascular cognitive impairment
Hui Lu, Mingxi Dang, Kewei Chen, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Kapβ2 Inhibits Perioperative Neurocognitive Disorders in Rats with Mild Cognitive Impairment by Reversing the Nuclear-Cytoplasmic Mislocalization of hnRNPA2/B1
M Zhang, Feiyu Jia, Qiang Wang, et al.
Molecular Neurobiology (2023) Vol. 61, Iss. 7, pp. 4488-4507
Closed Access | Times Cited: 3
Efficacy and Safety of Kleeb Bua Daeng Formula in Mild Cognitive Impairment Patients: A Phase I Randomized, Double-Blind, Placebo-Controlled Trial
Natdanai Musigavong, Chantana Boonyarat, Yaowared Chulikhit, et al.
Evidence-based Complementary and Alternative Medicine (2022) Vol. 2022, pp. 1-8
Open Access | Times Cited: 5
Study on network pharmacology of Ginkgo biloba extract against ischaemic stroke mechanism and establishment of UPLC‐MS/MS methods for simultaneous determination of 19 main active components
Chun‐Yan Yin, Yuanpei Lian, Jian‐Da Xu, et al.
Phytochemical Analysis (2023) Vol. 35, Iss. 2, pp. 254-270
Open Access | Times Cited: 2
Early intervention and adding effective doses of EGb761 like Ginkgo extract slow down dementia progression: insights to the neurovascular unit
Aynur Özge, Reza Ghouri, Nevra Öksüz, et al.
Frontiers in Neurology (2023) Vol. 14
Open Access | Times Cited: 2
Dementia in India: An Overview
Neeru Chaudhary
(2023)
Open Access | Times Cited: 1
Effectiveness of ginkgo diterpene lactone meglumine on cognitive function in patients with acute ischemic stroke
Meini Zhang, Xiao Hu, Tao Wang, et al.
Open Medicine (2024) Vol. 19, Iss. 1
Open Access
Therapeutic Efficacy of Xingnaojing Injection in Conjunction with Ginkgo biloba Extract in Managing Post-stroke Cognitive Impairment
Zhongze Chen, Hong Yu, Dan Ye, et al.
Indian Journal of Pharmaceutical Sciences (2024) Vol. 86, Iss. S2
Open Access
Page 1 - Next Page

Scroll to top